<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cahillane M</submitter><funding>European Blood Alliance (EBA)</funding><pagination>1123-1131</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12602124</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>120(11)</volume><pubmed_abstract>&lt;h4>Background and objectives&lt;/h4>The Welsh Blood Service (WBS) produces pooled platelet concentrates from four buffy coats (4BC-PC), achieving consistently high platelet yields exceeding the UK specification. Three buffy coat platelet concentrates (3BC-PC) offer the potential for improved supply chain resilience and increased production capacity. Data modelling was performed to evaluate the local feasibility of 3BC-PC production.&lt;h4>Materials and methods&lt;/h4>Platelet recovery (%) was calculated from 41 4BC-PC to generate three reference values (maximum, average and minimum). Measurements from the 164 BCs were used to model 3BC-PC production, with further analysis determining the impacts of manufacturing variability. Calculated yields were assessed against UK, European (EU) and UK continge</pubmed_abstract><journal>Vox sanguinis</journal><pubmed_title>Three buffy coat platelet concentrates: Use of data modelling to make more with less.</pubmed_title><pmcid>PMC12602124</pmcid><funding_grant_id>2022-02</funding_grant_id><pubmed_authors>Saunders C</pubmed_authors><pubmed_authors>Polidano N</pubmed_authors><pubmed_authors>Pearce N</pubmed_authors><pubmed_authors>Paletto L</pubmed_authors><pubmed_authors>O'Brien S</pubmed_authors><pubmed_authors>Cahillane M</pubmed_authors><pubmed_authors>George C</pubmed_authors><pubmed_authors>Scorer T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Three buffy coat platelet concentrates: Use of data modelling to make more with less.</name><description>&lt;h4>Background and objectives&lt;/h4>The Welsh Blood Service (WBS) produces pooled platelet concentrates from four buffy coats (4BC-PC), achieving consistently high platelet yields exceeding the UK specification. Three buffy coat platelet concentrates (3BC-PC) offer the potential for improved supply chain resilience and increased production capacity. Data modelling was performed to evaluate the local feasibility of 3BC-PC production.&lt;h4>Materials and methods&lt;/h4>Platelet recovery (%) was calculated from 41 4BC-PC to generate three reference values (maximum, average and minimum). Measurements from the 164 BCs were used to model 3BC-PC production, with further analysis determining the impacts of manufacturing variability. Calculated yields were assessed against UK, European (EU) and UK continge</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T15:11:27.214Z</modification><creation>2026-05-18T03:13:05.361Z</creation></dates><accession>S-EPMC12602124</accession><cross_references><pubmed>40789580</pubmed><doi>10.1111/vox.70090</doi></cross_references></HashMap>